Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-12-04T19:40:32.855Z Has data issue: false hasContentIssue false
  • English
  • Français

Antiprogestin Drugs: Ethical Issues

Published online by Cambridge University Press:  29 April 2021

Ruth Macklin
Get access Rights & Permissions [Opens in a new window]

Extract

Does the prospect of introducing RU 486 into the United States pose any unique ethical issues? Or are the ethical questions raised by antiprogestins similar to those that arise when any new medical technology comes along? The short answer is that the ethical issues are not new or different, but the politics of abortion can seduce us into thinking that antiprogestins bear ethical hazards of a novel sort.

One transcending ethical question stands before us: Would it be the right thing to do to introduce RU 486 into the United States today? The deceptive simplicity of that question requires further analysis.

Type
Ethical and Legal Issues
Information
Law, Medicine and Healthcare , Volume 20 , Issue 3 , Fall 1992 , pp. 215 - 219
Copyright
© 1992 American Society of Law, Medicine & Ethics

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gervais, Karen and Miles, Steven, “RU 486: New Issues in the American Abortion Debate”, unpublished report from the Center For Biomedical Ethics, University of Minnesota (1990), 9, citing Urquhart, D.R. and Templeton, A.A., “Acceptability of Medical Pregnancy Termination”, Lancet, 2 (July 1988): 106.Google Scholar
Grimes, David, “RU 486: Politics and Science Collide”, Los Angeles Times, June 17, 1991.Google Scholar
Rust v. Sullivan, 111 S.Ct. 1759 (1991).Google Scholar
Grimes, David, supra note 2.Google Scholar
Cook, Rebecca, ” Los Angeles Times, June 18, 1991, sec. B7.Google Scholar
Callahan, Sidney, “The First Stage of Life Is Life,” Los Angeles Times, June 19, 1991.Google Scholar
Ibid.Google Scholar
McFadden, Robert D., “Abortion Mills Thriving Behind Secrecy and Fear”, New York Times, Nov. 24, 1991, sec. A1.Google Scholar
Gervais, and Miles, , supra note 1, at 14.Google Scholar
Ibid.Google Scholar
Gervais, and Miles, , supra note 1, citing Urquhart, at 9.Google Scholar
Dr.Toubia, Nahid, “Between the Concorde and the Horse-Carriage: How Do We Cross the Development Gap with Medical Abortifacients?” unpublished paper presented at the International Symposium on Antiprogestins, Dhaka, Bangladesh, October 7–8, 1991, 10–11.Google Scholar
Grimes, David, supra note 1, at 15.Google Scholar
Kabir, Sandra and Germain, Adrienne, “Is RU 486 Likely to be Appropriate for Women in Bangladesh?” paper presented at the International Symposium on Antiprogestins, Dhaka, Bangladesh, October 7–8, 1991, 12.Google Scholar
Grimes, David, supra note 2.Google Scholar